Clinical Trial Update: Compassionate Use of Ubamatamab

View source ↗

Summary

The document notes compassionate-use access to Ubamatamab for renal medullary carcinoma and epithelioid sarcoma, sponsored by Regeneron, with the trial status l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelioid Sarcoma
• Renal Medullary Carcinoma

Drugs mentioned

• Ubamatamab (ubamatamab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Renal Medullary Carcinoma (RMC), Epithelioid Sarcoma | Status: AVAILABLE